Quick Answer
FATE THERAPEUTICS INC reported Net Income of -$136.31 million for fiscal year 2025.
FATE THERAPEUTICS INC Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$136.31M | +26.8% |
| 2024 | -$186.26M | -15.7% |
| 2023 | -$160.93M | +42.9% |
| 2022 | -$281.72M | -32.8% |
| 2021 | -$212.15M | -22.4% |
| 2020 | -$173.39M | -76.7% |
| 2019 | -$98.15M | -47.4% |
| 2018 | -$66.60M | -55.1% |
| 2017 | -$42.95M | -28.4% |
| 2016 | -$33.46M | -11.6% |
| 2015 | -$29.99M | -15.9% |
| 2014 | -$25.88M | -23.9% |
| 2013 | -$20.89M | -46.7% |
| 2012 | -$14.24M | -6.0% |
| 2011 | -$13.43M | +17.2% |
| 2010 | -$16.22M | -21.7% |
| 2009 | -$13.33M | -86.0% |
| 2008 | -$7.17M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$32.25M | +32.4% | +5.3% |
| June 30, 2025 | -$34.07M | +11.3% | +9.4% |
| March 31, 2025 | -$37.62M | +21.6% | +21.1% |
| September 30, 2024 | -$47.68M | -5.6% | -24.1% |
| June 30, 2024 | -$38.43M | +27.2% | +20.0% |
| March 31, 2024 | -$48.00M | -154.2% | -6.3% |
| September 30, 2023 | -$45.17M | +45.9% | +14.4% |
| June 30, 2023 | -$52.76M | +30.7% | -179.4% |
- FATE THERAPEUTICS INC showed an increase of +26.8% in Net Income compared to the prior fiscal year.
- Over the 2008–2025 period, FATE THERAPEUTICS INC’s net income has declined by 1801.5% (from -$7.17 million to -$136.31 million).
- The most recent figure is from FATE THERAPEUTICS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: